JAKARTA. The Extraordinary General Shareholders Meeting of PT Kimia Farma Tbk (KAEF) approved the plan of raising its capital by offering new shares with preemptive rights. The rights issue would involve 2,779,397,000 Series B shares with a face value of IDR 100 each.
The said meeting, conducted on Wednesday (18/8), also decided that the proceeds of the limited public offering would be channelled to cover several maturing debts, fund the working capital, and expand the business. Furthermore, it also includes developing the digital transformation and the information technology system.
The shareholders meeting, organised virtually with the e-proxy system, collected the attendance of 90.28% of the total shareholders. The e-proxy system provided by Indonesia Central Securities Depository (lit. Kustodian Sentral Efek Indonesia/KSEI) has allowed the shareholders to exercise their votes online. (AM/ZH)